EGFR and hereditary sensory and autonomic neuropathy: We discovered that both the EGFR and ALK wild-type non-squamous subgroups, as well as the squamous subgroups, exhibited a higher risk of CIP in the ICI group compared to chemotherapy, irrespective of the grade (all grades or grade 3–5).